Riyadh – Mubasher: Jamjoom Pharmaceuticals Factory Company (Jamjoom Pharma) is participating in the 43rd Annual J.P. Morgan Healthcare Conference that is taking place in the US, according to a press release.
The conference is being held on 13-16 January 2025 at The Westin St. Francis hotel in San Francisco.
Jamjoom Pharma is by far the first-ever Saudi company presenting at this prestigious conference where more than 8,000 healthcare leaders and investors gather annually to discuss the most pressing topics in the pharmaceuticals sector.
The company was recently mentioned among the top entities trading on the All Share Index (TASI) of the Saudi Exchange (Tadawul) in 2025.
Meanwhile, during the first nine months (9M) of 2024, Jamjoom Pharma generated net profits worth SAR 304.92 million compared to SAR 247.92 million in 9M-23.
